Pomalyst and Mometasone furoate drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 28 people who take Pomalyst and Mometasone furoate. Common interactions include malaise among females, and back pain among males.
The phase IV clinical study analyzes what interactions people who take Pomalyst and Mometasone furoate have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
28 people who take Pomalyst and Mometasone furoate together, and have interactions are studied.
What is Pomalyst?
Pomalyst has active ingredients of pomalidomide. Currently, eHealthMe is studying from 73,890 Pomalyst users.
What is Mometasone furoate?
Mometasone furoate has active ingredients of mometasone furoate. It is used in asthma. Currently, eHealthMe is studying from 10,212 Mometasone furoate users.
Number of Pomalyst and Mometasone furoate reports submitted per year:
Common Pomalyst and Mometasone Furoate drug interactions by gender *:
- Drug ineffective
- Throat cancer
- Vocal cord paralysis
- Back pain
- Blood glucose increased
- Jaw fracture
- Muscle spasms
- Muscular weakness
- T-lymphocyte count decreased
- White blood cell count decreased
- Adverse drug reaction
Common Pomalyst and Mometasone Furoate drug interactions by age *:
- Adverse drug reaction
- Mouth ulceration
- Muscle spasms
- Palmar-plantar erythrodysaesthesia syndrome
- Plasma cell myeloma
- Skin disorder
Common conditions people have *:
- Multiple Myeloma (cancer of the plasma cells): 25 people, 89.29%
* Approximation only. Some reports may have incomplete information.
Do you take Pomalyst and Mometasone furoate?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drug side effects by duration, gender and age:
Common Pomalyst drug interactions:
- Pomalyst and Aspirin: 10,057 reports
- Pomalyst and Gabapentin: 4,322 reports
- Pomalyst and Vitamin d: 4,275 reports
- Pomalyst and Revlimid: 4,114 reports
- Pomalyst and Dexamethasone: 4,061 reports
- Pomalyst and Amlodipine: 3,291 reports
- Pomalyst and Omeprazole: 3,274 reports
- Pomalyst and Ninlaro: 2,844 reports
- Pomalyst and Darzalex: 2,741 reports
- Pomalyst and Velcade: 2,613 reports
Browse interactions between Pomalyst and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Mometasone furoate drug interactions:
- Mometasone furoate and Prednisone: 2,124 reports
- Mometasone furoate and Omeprazole: 1,264 reports
- Mometasone furoate and Furosemide: 1,233 reports
- Mometasone furoate and Vitamin d: 1,225 reports
- Mometasone furoate and Albuterol: 1,186 reports
- Mometasone furoate and Xyrem: 1,141 reports
- Mometasone furoate and Pantoprazole: 1,058 reports
- Mometasone furoate and Gabapentin: 974 reports
- Mometasone furoate and Albuterol sulfate: 964 reports
- Mometasone furoate and Aspirin: 951 reports
Browse interactions between Mometasone furoate and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on pomalidomide and mometasone furoate (the active ingredients of Pomalyst and Mometasone furoate, respectively), and Pomalyst and Mometasone furoate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Pomalyst and Mometasone furoate.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Morphine Sulfate and Poor Venous Access - 13 seconds ago
- Oxymorphone Hydrochloride and Oedema Peripheral - 20 seconds ago
- Mycostatin and Renagel drug interaction - 24 seconds ago
- Rocklatan and Gabapentin drug interaction - 25 seconds ago
- Actonel and Evista drug interaction - 33 seconds ago
- Lotrel and Teveten drug interaction - 35 seconds ago
- Mavik and Etoposide drug interaction - 36 seconds ago
- Drospirenone And Ethinyl Estradiol and Sertraline Hydrochloride drug interaction - 41 seconds ago
- Novalgin and Calcium Gluconate drug interaction - a minute ago
- Ceftaroline Fosamil and Thrombocytopenia - a minute ago